ChemPartner is a global drug discovery CRO delivering cutting-edge biology, chemistry, and bioanalytical services to advance cardiovascular and metabolic disease research. At the Cardiometabolic Networking Summit 2025, we’re meeting with industry leaders to accelerate the development of novel cardiometabolic therapeutics.

Cardiometabolic Research with ChemPartner

Diabetes and Obesity Models

• Diet-induced Obesity (DIO) Mouse Model
• Mouse Models of Type 2 Diabetes & Obesity
• Type 1 Diabetes Mouse Model
• Short-term Food Intake and Glucose Tolerance Testing in Mice
• High-fat Diet + Streptozotocin-induced T2D in Mice

Liver Disease Models

• Gubra-Amylin NASH (GAN) Diet-induced NASH
• CDA High-fat Diet-induced NASH
• High-fat Diet-induced NASH in Mice
• CCL4-induced Liver Fibrosis

Renal Disease Models

• Unilateral Ureteral Obstruction-induced Kidney Fibrosis in Mice
• 0.2% Adenine Diet-induced CKD in Mice
• Calcium-free Oxalate Diet-induced CKD in Mice
• Cisplatin-induced Acute Kidney Disease in Mice
• Unilateral Ischemia-reperfusion Injury (UIRI) and Unilateral Nephrectomy (UNX)-induced Acute Kidney Injury in Mice

Cardiovascular Disease Models

• High-fat Diet-induced Atherosclerosis